Danaher Co. (NYSE:DHR) SVP Sells $2,641,536.00 in Stock

Danaher Co. (NYSE:DHR) SVP Brian W. Ellis sold 9,600 shares of the stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $275.16, for a total transaction of $2,641,536.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at $5,566,486.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Danaher Trading Up 1.4 %

DHR opened at $273.91 on Monday. The business’s 50 day moving average price is $255.16 and its 200 day moving average price is $249.35. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.51 and a current ratio of 1.43. The stock has a market capitalization of $202.88 billion, a PE ratio of 46.43, a P/E/G ratio of 4.24 and a beta of 0.84. Danaher Co. has a one year low of $182.09 and a one year high of $277.72.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, July 23rd. The conglomerate reported $1.72 EPS for the quarter, beating the consensus estimate of $1.57 by $0.15. The business had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 11.06% and a net margin of 16.94%. The company’s quarterly revenue was down 2.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.05 EPS. As a group, equities research analysts expect that Danaher Co. will post 7.59 EPS for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, July 26th. Shareholders of record on Friday, June 28th were given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.39%. The ex-dividend date was Friday, June 28th. Danaher’s dividend payout ratio is presently 18.31%.

Analyst Ratings Changes

Several research firms have issued reports on DHR. HSBC raised shares of Danaher from a “hold” rating to a “buy” rating and increased their price objective for the company from $250.00 to $280.00 in a report on Wednesday, April 17th. Evercore ISI decreased their price objective on shares of Danaher from $266.00 to $260.00 and set an “outperform” rating on the stock in a report on Tuesday, July 2nd. Royal Bank of Canada increased their price objective on shares of Danaher from $297.00 to $300.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. TD Cowen increased their price objective on shares of Danaher from $290.00 to $310.00 and gave the company a “buy” rating in a report on Wednesday, July 24th. Finally, Bank of America raised their price target on shares of Danaher from $270.00 to $275.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 24th. Six analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $276.88.

Hedge Funds Weigh In On Danaher

Large investors have recently made changes to their positions in the stock. Norges Bank acquired a new position in Danaher during the fourth quarter worth $1,752,382,000. Vanguard Group Inc. lifted its stake in Danaher by 7.4% during the 1st quarter. Vanguard Group Inc. now owns 60,107,030 shares of the conglomerate’s stock worth $15,009,928,000 after acquiring an additional 4,163,657 shares in the last quarter. Wellington Management Group LLP boosted its holdings in Danaher by 12.0% during the 4th quarter. Wellington Management Group LLP now owns 27,928,442 shares of the conglomerate’s stock valued at $6,460,966,000 after acquiring an additional 2,998,161 shares during the period. Swedbank AB purchased a new position in Danaher during the 1st quarter valued at about $676,545,000. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main grew its position in Danaher by 214.4% in the 4th quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 3,073,661 shares of the conglomerate’s stock valued at $711,051,000 after acquiring an additional 2,096,038 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.